Jiangsu Trulive Medical

Jiangsu Trulive Medtech is a high-tech medical device company specializing in the development and manufacturing of interventional medical devices for cardiovascular and peripheral vascular applications. Founded in 2019 and headquartered in Nantong, China, the company focuses on blood flow management through a platform of minimally invasive surgical tools. Its flagship products include the NeoNova transcatheter mitral valve repair system and the DEEPQUAKE series of intravascular lithotripsy (shockwave) systems for treating vascular calcification. Trulive Medtech has established strategic partnerships with Grand Pharmaceutical for the commercialization of its innovative device portfolio. The company is backed by prominent venture capital firms and has successfully advanced multiple programs to the commercial stage in the Chinese market.